Loading clinical trials...
Loading clinical trials...
This study examined whether dietary-induced reductions in lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in peripheral blood mononuclear cells (PBMC) and plasma affected metabolic profiles in PBMCs and plasma.
Eighty nonobese patients (aged 40-70 years) with prediabetes or newly diagnosed type-2 diabetes were randomly assigned to a control group (normal diet with refined rice) or a whole-grain group (replacement of refined rice with whole-grains and legumes). This dietary intervention replaced approximately 7% of carbohydrate-derived energy with approximately 4% of protein-derived energy and approximately 3% of fat-derived energy.
Age
40 - 70 years
Sex
ALL
Healthy Volunteers
No
Yonsei University
Seoul, South Korea
Start Date
January 1, 2013
Primary Completion Date
June 1, 2013
Completion Date
June 1, 2013
Last Updated
July 16, 2014
82
ACTUAL participants
Dietary intervention-refined rice
DIETARY_SUPPLEMENT
Dietary intervention-whole grains and legumes
DIETARY_SUPPLEMENT
Lead Sponsor
Yonsei University
NCT05119179
NCT06252038
NCT04943861
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions